Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ANCHOR - Assessment of Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care

NCT06422689 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06422689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06422689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ANCHOR - Assessment of Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care
Lead sponsor
AstraZeneca
Phase
Phase 4
Overall status
Active, not recruiting
Start date
May 10, 2024
Completion date
February 3, 2027
Enrollment
1,511 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

asthma